InspireMD Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
127
- Stock Symbol
-
NSPR
- Investments
-
1
- Share Price
-
$0.68
- (As of Wednesday Closing)
InspireMD General Information
Description
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Contact Information
Website
www.inspiremd.comCorporate Office
- 6303 Waterford District Drive
- Suite 215
- Miami, FL 33126
- United States
Corporate Office
- 6303 Waterford District Drive
- Suite 215
- Miami, FL 33126
- United States
InspireMD Timeline
InspireMD Stock Performance
As of 18-Nov-2026, InspireMD’s stock price is $0.68. Its current market cap is $37.1M with 54.1M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.68 | $0.65 | $0.43 - $2.17 | $37.1M | 54.1M | 219K | -$0.59 |
InspireMD Financials Summary
As of 30-Sep-2026, InspireMD has a trailing 12-month revenue of $10.6M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,649 | 15,390 | 29,426 | 19,115 |
| Revenue | 10,560 | 8,979 | 7,009 | 6,205 |
| EBITDA | (49,842) | (49,138) | (33,223) | (20,911) |
| Net Income | (49,536) | (48,786) | (32,005) | (19,916) |
| Total Assets | 33,568 | 69,404 | 46,807 | 47,643 |
| Total Debt | 2,749 | 3,290 | 2,338 | 1,595 |
InspireMD Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InspireMD Comparisons
Industry
Financing
Details
InspireMD Competitors (5)
One of InspireMD’s 5 competitors is Boston Scientific, a Corporation company based in Marlborough, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Atricure | Formerly VC-backed | Mason, OH | ||||
| CardioFocus | Venture Capital-Backed | Marlborough, MA | ||||
| Oscor | Corporate Backed or Acquired | Palm Harbor, FL |
InspireMD Patents
InspireMD Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250235595-A1 | Intravascular sheath | Pending | 18-Jan-2024 | ||
| WO-2025154053-A1 | Intravascular sheath | Pending | 18-Jan-2024 | ||
| EP-4572831-A1 | Devices for shunting blood | Pending | 17-Aug-2022 | ||
| EP-4572831-A4 | Devices for shunting blood | Pending | 17-Aug-2022 | ||
| US-12661490-B2 | Devices for shunting blood | Active | 17-Aug-2022 | A61M39/0613 |
InspireMD Signals
InspireMD Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
InspireMD Acquisitions (1)
InspireMD’s most recent deal was a Merger/Acquisition with Saguaro Resources (Mineral Exploration Services). The deal was made on 28-Mar-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Saguaro Resources (Mineral Exploration Services) | 28-Mar-2011 | Merger/Acquisition | Other Metals, Minerals and Mining |
InspireMD ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
InspireMD FAQs
-
When was InspireMD founded?
InspireMD was founded in 2005.
-
Where is InspireMD headquartered?
InspireMD is headquartered in Miami, FL.
-
What is the size of InspireMD?
InspireMD has 127 total employees.
-
What industry is InspireMD in?
InspireMD’s primary industry is Therapeutic Devices.
-
Is InspireMD a private or public company?
InspireMD is a Public company.
-
What is InspireMD’s stock symbol?
The ticker symbol for InspireMD is NSPR.
-
What is the current stock price of InspireMD?
As of 18-Nov-2026 the stock price of InspireMD is $0.68.
-
What is the current market cap of InspireMD?
The current market capitalization of InspireMD is $37.1M.
-
What is InspireMD’s current revenue?
The trailing twelve month revenue for InspireMD is $10.6M.
-
Who are InspireMD’s competitors?
Boston Scientific, Medtronic, Atricure, CardioFocus, and Oscor are competitors of InspireMD.
-
What is InspireMD’s annual earnings per share (EPS)?
InspireMD’s EPS for 12 months was -$0.59.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process